Specialty Copays up 26%; Generic and Brand Copays up 10% to 13%
PLANO, TX--(Marketwire - Dec 19, 2012) - Retail copays are on the rise again across all drug types, including generics, brands and specialty drugs. This is just one of the reported results from the 2012-2013 Prescription Drug Benefit Cost and Plan Design Report published by the Pharmacy Benefit Management Institute (PBMI).
"Readers of this report can expect to see all of the survey results broken out by larger and smaller employers, a new change for this year," said Brenda Motheral, PhD, Executive Director of PBMI. "This report is the only industry report that captures data provided by plan sponsors about their pharmacy discount rates; and this year, we had a record number of plan sponsors sharing details about their pharmacy reimbursement and rebate amounts."
The 2012 survey was completed by 424 U.S. employers representing an estimated 3.7 million members.
Requests for online and print copies of the report are available via www.pbmi.com.
About the Pharmacy Benefit Management Institute
The Pharmacy Benefit Management Institute provides research and continuing education to help health care benefit executives work effectively with pharmacy benefit managers to improve the design and management of drug benefit programs.
Contact Information:
Contact:
PBMI
480-730-0814
Email: